Expressed in Medical Technology
Navigation Links
Expressed in Medical Technology
... receptor known as 'CCR9', which is selectively expressed by inflammatory T cells to migrate to the ... In adults, CCR9 is a highly specific receptor expressed by T cells that migrate selectively to the ... levels of activity, performance or achievements expressed or implied by any forward-looking statement. Some ...
... in the CXC chemokine receptor family that is expressed on a variety of cancers including leukemias, ... a component of the cell plasma membrane, that is expressed on most small cell lung cancers (SCLC). In in ... Glypican-3 is a protein that has been shown to be expressed in liver cancer. A panel of fully human ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... that targets CD30, a member of the TNF family expressed on CD30-positive lymphomas, including ... that selectively binds to CD19, a molecule expressed on a broad range of B-cell malignancies. MDX-1342 ... program. -- MDX-1203 targets the CD70 molecule expressed on multiple cancers and is expected to be the ...
... specific type of immune system whose tumor cells expressed a specific antigen. More studies are needed to ... to 75 percent of the patient's tumor cells expressed the NY-ESO-1 antigen, the entire tumor regressed ... immune response was broadened to other antigens expressed by the tumor cells. Follow-up tests showed T cell ...
... actual results to differ materially from those expressed or implied by such statements. In particular, ... actual results to differ materially from those expressed or implied by forward-looking statements include, ... time means that actual events are bearing out as expressed or implied in such forward-looking statements. ...
... molecule (EpCAM or CD326), which is highly expressed on colon, lung, breast, prostate, ... historical results or from any future results expressed or implied by such forward-looking statements. ... to differ materially from any future results expressed or implied by any forward-looking statements ...
... on normal cells, but is exposed and highly expressed on melanoma cells. Consistent with ... historical results or from any future results expressed or implied by such forward-looking statements. ... to differ materially from any future results expressed or implied by any forward-looking statements ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... that could cause actual results to differ materially from those expressed or implied by such statements. In particular, clinical trial data are ... medical and scientific experts and others may differ from ours or those expressed in the referenced publication. The Phase 3 clinical trial data presented ...
... in hepatitis C, or any potential pipeline candidates, including any expressed or implied statements regarding the efficacy and safety of IDX184, the ... materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantees that the company ...
... be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking ... that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product ...
... be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking ... that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product ...
... negative human breast carcinomas and discovered that the protein EZH-2 was expressed in 74 percent of those cases. Hormone receptor negative breast carcinoma ... of the protein was present. We were surprised that 74 percent of tumors expressed that EZH-2 protein." Sixty-one samples that researchers used were ...
... The CD20 molecule is a key target in CLL therapy because it is highly expressed in most B-cell malignancies. Ofatumumab is being developed under a ... performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our ...
... that could cause actual results to differ materially from those expressed or implied by such statements. In particular, clinical trial data are ... that could cause actual results to differ materially from those expressed or implied by forward-looking statements include, among others, risks ...
Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
... is a target antigen that is highly and frequently expressed on many types of solid tumors. MT110 currently ... historical results or from any future results expressed or implied by such forward-looking statements. ... to differ materially from any future results expressed or implied by any forward-looking statements ...... in the CXC chemokine receptor family that is expressed on a variety of cancers including leukemias, ... a component of the cell plasma membrane, that is expressed on most small cell lung cancers (SCLC). In in ... Glypican-3 is a protein that has been shown to be expressed in liver cancer. A panel of fully human ...
Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
... EpCAM is a cancer target which is highly expressed in colorectal cancer, and targeted therapies such ... Apart from being the most highly and frequently expressed target antigen on colorectal cancer cells, EpCAM ... been shown to drive tumor growth and to be expressed on colorectal cancer stem cells (1). The ability ...Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. ...... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...... that targets CD30, a member of the TNF family expressed on CD30-positive lymphomas, including ... that selectively binds to CD19, a molecule expressed on a broad range of B-cell malignancies. MDX-1342 ... program. -- MDX-1203 targets the CD70 molecule expressed on multiple cancers and is expected to be the ...
Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...... specific type of immune system whose tumor cells expressed a specific antigen. More studies are needed to ... to 75 percent of the patient's tumor cells expressed the NY-ESO-1 antigen, the entire tumor regressed ... immune response was broadened to other antigens expressed by the tumor cells. Follow-up tests showed T cell ...
Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Promise of Vical's CMV Vaccine Noted by Independent Experts
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
... actual results to differ materially from those expressed or implied by such statements. In particular, ... actual results to differ materially from those expressed or implied by forward-looking statements include, ... time means that actual events are bearing out as expressed or implied in such forward-looking statements. ...... actual results to differ materially from those expressed or implied by such statements. In particular, ... actual results to differ materially from those expressed or implied by forward-looking statements include, ... time means that actual events are bearing out as expressed or implied in such forward-looking statements. ...
... molecule (EpCAM or CD326), which is highly expressed on colon, lung, breast, prostate, ... historical results or from any future results expressed or implied by such forward-looking statements. ... to differ materially from any future results expressed or implied by any forward-looking statements ...
Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
... DNA immunotherapeutics for cancer, in which the expressed protein is an immune system stimulant; DNA vaccines for infectious diseases, in which the expressed protein is an immunogen; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...... on normal cells, but is exposed and highly expressed on melanoma cells. Consistent with ... historical results or from any future results expressed or implied by such forward-looking statements. ... to differ materially from any future results expressed or implied by any forward-looking statements ...
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Interim Safety Data Favorable for Vical's Phase 2 Trial of DNA Vaccine Against CMV
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results
... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...... for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The ...
... that could cause actual results to differ materially from those expressed or implied by such statements. In particular, clinical trial data are ... medical and scientific experts and others may differ from ours or those expressed in the referenced publication. The Phase 3 clinical trial data presented ...
... in hepatitis C, or any potential pipeline candidates, including any expressed or implied statements regarding the efficacy and safety of IDX184, the ... materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantees that the company ...
MADIT-CRT Trial Meets Primary Endpoint
... actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some ... results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place ...... be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking ... that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product ...
... be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking ... that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product ...
... negative human breast carcinomas and discovered that the protein EZH-2 was expressed in 74 percent of those cases. Hormone receptor negative breast carcinoma ... of the protein was present. We were surprised that 74 percent of tumors expressed that EZH-2 protein." Sixty-one samples that researchers used were ...
... The CD20 molecule is a key target in CLL therapy because it is highly expressed in most B-cell malignancies. Ofatumumab is being developed under a ... performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our ...
... that could cause actual results to differ materially from those expressed or implied by such statements. In particular, clinical trial data are ... that could cause actual results to differ materially from those expressed or implied by forward-looking statements include, among others, risks ...
Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop
... infusion. Our actual results could differ materially from those results expressed in, or implied by, these forward-looking statements. The development and ... could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this ...Other ContentsareataalopeciaalopeciaalopeciafetoproteinantitrypsinOther Tagsdrawdrawdraw
(Date:11/26/2009)...ut a way of using recordings of birdsong to accura... the first time sound recordings from a microphone...s of bird species, populations. Because the new te...y,s Journal of Applied Ecology , will also work w...n our ability to monitor whale and dolphin numbers...
(Date:11/26/2009)... What are the bare essentials of life, the indisp...t can survive on its own? Can we describe the mole...ire organism functions as a system? These are just...rship between the European Molecular Biology Labor...e de Regulacio Genmica (CRG) in Barcelona, Spain, ...
(Date:11/25/2009)...he stomach, may be used to boost resistance to, or...e School of Medicine researchers report in a study...uroscience . , Parkinson,s disease is caused by ...he midbrain known as the substantia nigra, which i...oduction of dopamine in late-stage Parkinson,s cau...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Butterfly proboscis to sip cells 10852 1Go Healthy Not Hungry for Holiday Eating 61888 1Go Healthy Not Hungry for Holiday Eating 61888 2Waterproof Cleanable Computer Keyboard Video Comparison Now Available on You Tube 61885 1Waterproof Cleanable Computer Keyboard Video Comparison Now Available on You Tube 61885 2(Date:11/27/2009)... anatomy education apps from Modality and Lippinco...earning opportunities for iPhone and iPod touch ,...er 27, 2009 -- Modality, Inc. and Lippincott Wil...luwer Health, today announced the availability of ... Clemente’s Anatomy, Rohen’s Photograp...
(Date:11/26/2009)... living with diabetes will nearly double, increasi...34. Over the same period, spending on diabetes wil...billion, even with no increase in the prevalence o...Chicago report in the December issue of Diabetes ...ed by Medicare will rise from 8.2 million to 14.6 ...
(Date:11/26/2009)...ollercoaster, study finds , , THURSDAY, ...r meets the jubilant sports fan. , A new study ...oot for the winning team -- enjoy the greatest sat...ctory was in doubt, producing feelings of worry an...g weekend as you,re glued to the TV set, watching ...
(Date:11/26/2009)...tal (RTDental), a leading dental group practice in...sion of its services to include LUMINEERS by a cer... Durham, NC (PRWEB) -- Res...Dr. Doug Macmillan, an experienced LUMINEERS Den...aining seminar. RTDental’s ability to fulfi...
(Date:11/25/2009)...SNewswire/ -- When most people hear the acronym TM...r can also give patients the help they need. TMJ s...where your jaw (mandible) contacts/connects with y...symptoms associated with TMJ dysfunction are pain ... many other symptoms can be caused from TMJ dysfun...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store[0] Diabetes cases to double and costs to triple by 2034[0] Watching the Nail-Biting Big Game Hurts So Good[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental [1] TMJ and Chiropractic Care: An Overall Wellness Approach
neuropeptidesexamineddrawfoilingacceleratingterraininterruptionpaintersunderestimatedimmunologistsrelentlesswoesinhalationalpostexposure
Other Tagscant 2cant 3ago 2ago 3ago 4ago 5ago 6ago 7ago 8ago 9ago 10continued 2continued 3continued 4continued 5continued 6continued 7continued 8continued 9continued 10decisions 2decisions 3decisions 4decisions 5potent 2potent 3potent 4potent 5potent 6potent 7potent 8safer 2safer 3sperm 2sperm 3sperm 4sperm 5cocktail 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |